Pierandrea Muglia
Director/Board Member at SANA AB
Profile
Pierandrea Muglia is an Independent Director at Saniona AB since 2023.
Previously, he worked as the Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A and as the Chief Marketing Officer at Handl Therapeutics BV.
Pierandrea Muglia active positions
Companies | Position | Start |
---|---|---|
SANA AB | Director/Board Member | 2022-12-31 |
Former positions of Pierandrea Muglia
Companies | Position | End |
---|---|---|
GRIN Therapeutics, Inc. | Founder | 2022-08-31 |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 2019-09-30 |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Sales & Marketing | - |
NTG NORDIC TRANSPORT GROUP A/S | Director/Board Member | 2010-05-27 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Private companies | 3 |
---|---|
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Health Technology |
GRIN Therapeutics, Inc. | |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
- Stock Market
- Insiders
- Pierandrea Muglia